BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21224015)

  • 1. The kaleidoscope of glucorticoid effects on immune system.
    Zen M; Canova M; Campana C; Bettio S; Nalotto L; Rampudda M; Ramonda R; Iaccarino L; Doria A
    Autoimmun Rev; 2011 Apr; 10(6):305-10. PubMed ID: 21224015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential.
    Vieira PL; Kaliński P; Wierenga EA; Kapsenberg ML; de Jong EC
    J Immunol; 1998 Nov; 161(10):5245-51. PubMed ID: 9820496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy.
    Tuckermann JP; Kleiman A; Moriggl R; Spanbroek R; Neumann A; Illing A; Clausen BE; Stride B; Förster I; Habenicht AJ; Reichardt HM; Tronche F; Schmid W; Schütz G
    J Clin Invest; 2007 May; 117(5):1381-90. PubMed ID: 17446934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect.
    Pitzalis C; Pipitone N; Bajocchi G; Hall M; Goulding N; Lee A; Kingsley G; Lanchbury J; Panayi G
    J Immunol; 1997 May; 158(10):5007-16. PubMed ID: 9144521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells.
    Godot V; Garcia G; Capel F; Arock M; Durand-Gasselin I; Asselin-Labat ML; Emilie D; Humbert M
    Allergy; 2006 Jul; 61(7):886-90. PubMed ID: 16792589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
    Stahn C; Löwenberg M; Hommes DW; Buttgereit F
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of mast cell activation by glucocorticoid.
    Yoshikawa H; Tasaka K
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):487-95. PubMed ID: 11197603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor.
    Almawi WY; Melemedjian OK
    J Leukoc Biol; 2002 Jan; 71(1):9-15. PubMed ID: 11781376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
    Greenstein S; Ghias K; Krett NL; Rosen ST
    Clin Cancer Res; 2002 Jun; 8(6):1681-94. PubMed ID: 12060604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration.
    Lim HY; Müller N; Herold MJ; van den Brandt J; Reichardt HM
    Immunology; 2007 Sep; 122(1):47-53. PubMed ID: 17451463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
    Benson M; Strannegård IL; Strannegård O; Wennergren G
    J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic and synergistic effects of glucocorticoids and IL-7 on CD4+ T cell activation.
    Cima I; Fuhrer A; Brunner T
    Immunol Lett; 2006 Jul; 106(1):99-102. PubMed ID: 16723155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide cooperates with glucocorticoids in thymic epithelial cell-mediated apoptosis of double positive thymocytes.
    Cohen O; Kfir-Erenfeld S; Spokoini R; Zilberman Y; Yefenof E; Sionov RV
    Int Immunol; 2009 Oct; 21(10):1113-23. PubMed ID: 19692538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta.
    Schmidt M; Pauels HG; Lügering N; Lügering A; Domschke W; Kucharzik T
    J Immunol; 1999 Sep; 163(6):3484-90. PubMed ID: 10477621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.